Deep Brain Stimulation for Tourette Syndrome

  • Jianuo Zhang
  • Yan Ge
  • Fangang Meng


Tourette syndrome (TS) is a chronic neurobehavioral disorder characterized by waxing and waning motor and phonic tics that persist for at least 12 months (Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497–501). It is also a multifactorial neurodevelopmental disorder that affects up to 1 % of children as well as many adults worldwide. The first clear description of this condition, published by Georges Albert Édouard Brutus Gilles de la Tourette in 1885 (de la Tourette GG. Étude sur une affection nerveuse caractérisée par de l’incoordination motrice accompagnée d’écholalie et de coprolalie (French). Arch Neurol. 1885;9:158–200), noted childhood onset of stereotyped, abnormal movements and vocalizations (called tics), heritability, coprolalia (the utterance of obscene or socially offensive words), echolalia (repeating other people’s words), and waxing and waning of symptoms; this description remains accurate and relevant today.


Attention Deficit Hyperactivity Disorder Globus Pallidus Internus Zona Incerta Obsessive Compulsive Behavior Beijing Tiantan Hospital 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67(6):497–501.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    de la Tourette GG. Étude sur une affection nerveuse caractérisée par de l’incoordination motrice accompagnée d’écholalie et de coprolalie (French). Arch Neurol. 1885;9:158–200.Google Scholar
  3. 3.
    Robertson MM. Tourette syndrome, associated conditions and the complexities of treatment. Brain. Mar 2000;123(3):425–62.PubMedCrossRefGoogle Scholar
  4. 4.
    Mink JW, Walkup J, Frey KA, et al. Patient selection and assessment recommendations for deep brain stimulation in Tourette syndrome. Mov Disord. 2006;21(11):1831–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Leckman JF. Tourette's syndrome. Lancet. 2002;360(9345):1577–86.Google Scholar
  6. 6.
    DSM-IV-TR. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington: American Psychiatric Association; 2000. p. 111–4.Google Scholar
  7. 7.
    ICD-10. International Classification of Disease and Related Health Problems. Classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. 10th ed. Geneva: World Health Organization; 1992, p. 284–6.Google Scholar
  8. 8.
    TSCS Group. Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group. Arch Neurol. 1993;50:1013–16. Google Scholar
  9. 9.
    Jankovic J. Tourette’s syndrome. N Engl J Med. 2001;345:1184–92.Google Scholar
  10. 10.
    Peterson BS, Skudlarski P, et al. A functional magnetic resonance imaging study of tic suppression in Tourette syndrome. Arch Gen Psychiatry. 1998;55:326–33.Google Scholar
  11. 11.
    Singer HS, Minzer K. Neurobiology of Tourette’s syndrome: concepts of neuroanatomic localization and neurochemical abnormalities. Brain Dev. 2003;25(Suppl 1):S70–84.PubMedCrossRefGoogle Scholar
  12. 12.
    Flaherty AW, Williams ZM, et al. Deep brain stimulation of the anterior internal capsule for the treatment of Tourette syndrome: technical case report. Neurosurgery. 2005;57(suppl 4):E403.PubMedCrossRefGoogle Scholar
  13. 13.
    Baker EFW. Gilles de la Tourette syndrome treated by bimedial leucotomy. Can Med Assoc J. 1962;86:746–7.PubMedCentralPubMedGoogle Scholar
  14. 14.
    Cooper IS. Dystonia reversal by operation in the basal ganglia. Arch Neurol. 1962;7:64–74.CrossRefGoogle Scholar
  15. 15.
    Stevens H. The syndrome of Gilles de la Tourette and its treatment. Med Ann District Columbia. 1964;36:277–9.Google Scholar
  16. 16.
    Hassler R, Dieckmann G. Stereotaxic treatment of tics and inarticulate cries or coprolalia considered as motor obsessional phenomena in Gilles de la Tourette’s disease. Rev Neurol (Paris). 1970;123:89–100.Google Scholar
  17. 17.
    Nadvornik P, Sramka M, Lisy L, Svicka I. Experiences with dentatotomy. Confin Neurol. 1972;34:320–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Beckers W. Gilles de la Tourette’s disease based on five own observations. Arch Psychiatr Nervenkr. 1973;217:169–86.PubMedGoogle Scholar
  19. 19.
    Wassman ER, Eldridge R, Abuzzahab S Sr, Nee L. Gilles de la Tourette syndrome: clinical and genetic studies in a midwesterncity. Neurology. 1978;28:304–7.PubMedCrossRefGoogle Scholar
  20. 20.
    Asam U, Karrass W. Gilles de la Tourette syndrome and psychosurgery. Acta Paedopsychiatr. 1981;47:39–48.PubMedGoogle Scholar
  21. 21.
    Hassler R. Stereotaxic surgery for psychiatric disturbances. In: Schaltenbrand G, Walker AE, editors. Stereotaxy of the human brain. New York: Thieme-Stratton Inc.; 1982. p. 570–90.Google Scholar
  22. 22.
    Cappabianca P, Spaziante R, Carrabs G, de Divitiis E. Surgical stereotactic treatment for Gilles de la Tourette’s syndrome. Acta Neurol (Napoli). 1987;9:273–80.Google Scholar
  23. 23.
    de Divitiis E, D’Errico A, Cerillo A. Stereotactic surgery in Gilles de la Tourette syndrome. Acta Neurochir (Wien) 1977; (Suppl. 24):73.Google Scholar
  24. 24.
    Robertson M, Doran M, Trimble M, Lees AJ. The treatment of Gilles de la Tourette syndrome by limbic leucotomy. J Neurol Neurosurg Psychiatry. 1990;53:691–4.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Sawle GV, Lees AJ, Hymas NF, Brooks DJ, Frackowiak RS. The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome. J Neurol Neurosurg Psychiatry. 1993;56:1016–9.PubMedCentralPubMedCrossRefGoogle Scholar
  26. 26.
    Rauch SL, Baer L, Cosgrove GR, Jenike MA. Neurosurgical treatment of Tourette’s syndrome: a critical review. Compr Psychiatry. 1995;36:141–56.PubMedCrossRefGoogle Scholar
  27. 27.
    Leckman JF, de Lotbiniere AJ, Marek K, Gracco C, Scahill L, Cohen DJ. Severe disturbances in speech, swallowing, and gait following stereotactic infrathalamic lesions in Gilles de la Tourette’s syndrome. Neurology. 1993;43:890–4.PubMedCrossRefGoogle Scholar
  28. 28.
    Baer L, Rauch SL, Ballantine HT Jr, et al. Cingulotomy for intractable obsessive compulsive disorder. Prospective long-term follow-up of 18 patients. Arch Gen Psychiatry. 1995;52:384–92.PubMedCrossRefGoogle Scholar
  29. 29.
    Korzenev AV, Shoustin VA, Anichkov AD, Polonskiy JZ. Nizkovo- los VB, Oblyapin AV. Differential approach to psychosurgery of obsessive disorders. Stereotact Funct Neurosurg. 1997;68:226–30.PubMedCrossRefGoogle Scholar
  30. 30.
    Vandewalle V, van der Linden C, Groenewegen HJ, Caemaert J. Stereotactic treatment of Gilles de la Tourette syndrome by high frequency stimulation of thalamus. Lancet. 1999;353:724.PubMedCrossRefGoogle Scholar
  31. 31.
    Porta M, Maggioni GR, Ottaviani F, Schindler A: Treatment of phonic tics in patients with Tourette’s syndrome using botulinum toxin type A. Neurol Sci. 2003;24:420–3.CrossRefGoogle Scholar
  32. 32.
    Porta M, Sassi M, et al. Tourette’s syndrome and role of tetrabenazine: review and personal experience. Clin Drug Investig. 2008;28:443–59.PubMedCrossRefGoogle Scholar
  33. 33.
    Servello D, Porta M, et al. Deep brain stimulation in 18 patients with severe Gilles de la Tourette syndrome refractory to treatment: the surgery and stimulation. J Neurol Neurosurg Psychiatry. 2008;79:136–42.PubMedCrossRefGoogle Scholar
  34. 34.
    Priori A, Giannicola G, Krauss JK, Simpson RK Jr, et al. Concepts and methods in chronic thalamic stimulation for treatment of tremor: technique and application. Neurosurgery. 2001;48:535–43.CrossRefGoogle Scholar
  35. 35.
    Houeto JL, Karachi C, et al. Tourette’s syndrome and deep brain stimulation. J Neurol Neuro surg Psychiatry. 2005;76:992–5.CrossRefGoogle Scholar
  36. 36.
    Katayama Y, Kano T, et al.: Difference in surgical strategies between thalamotomy and thalamic deep brain stimulation for tremor control. J Neurol 2005;252 (suppl 4):IV17–IV22.Google Scholar
  37. 37.
    Welter ML, Mallet L, et al. Internal pallidal and thalamic stimulation in patients with Tourette syndrome. Arch Neurol. 2008;65:952–7.PubMedGoogle Scholar
  38. 38.
    Sturm V, Lenartz D, et al. The nucleus accumbens: a target for deep brain stimulation in obsessive compulsive and anxiety-disorders. J Chem Neuroanat. 2003;26:293–9.PubMedCrossRefGoogle Scholar
  39. 39.
    Kuhn J, Lenartz D, et al. Deep brain stimulation of the nucleus accumbens and the internal capsule in therapeutically refractory Tourette syndrome. J Neurol. 2007;254:963–5.PubMedCrossRefGoogle Scholar
  40. 40.
    Hirabayashi H, Tengvar M, Hariz MI. Stereotactic imaging of the pallidal target. Mov Disord. 2002;17(Suppl 3):S130–4.PubMedCrossRefGoogle Scholar
  41. 41.
    Hu W, Klassen BT, Stead M. Surgery for movement disorders. J Neurosurg Sci. 2011;55:305–17.PubMedGoogle Scholar
  42. 42.
    Schiefer TK, Matsumoto JY, Lee KH. Moving forward: advances in the treatment of movement disorders with deep brain stimulation. Front Integr Neurosci. 2011;5:69.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Shanghai Jiao Tong University Press, Shanghai and Springer Science+Business Media Dordrecht 2015

Authors and Affiliations

  • Jianuo Zhang
    • 1
  • Yan Ge
    • 1
  • Fangang Meng
    • 1
  1. 1.Department of Neurosurgery, Beijing Tiantan HospitalCapital Medical UniversityBeijingChina

Personalised recommendations